GARY A LYONS Insider Trading $RTRX Travere Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GARY A LYONS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GARY A LYONS. GARY A LYONS is in Brickell Biotech, Inc. ($VICL) and Director in VICAL INC ($VICL) and Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in CYTORI THERAPEUTICS, INC. ($XMP) and Director in KALOBIOS PHARMACEUTICALS INC ($KBIO) and Director in Novus Therapeutics, Inc. ($TKAI) and Director in Retrophin, Inc. ($RTRX).
GARY A LYONS in Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GARY A LYONS: Director
Holdings: 37,000 shares
Current Value: $742,590
Latest Transaction: May 18 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GARY A LYONS in Travere Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, VICL, ELDN, KBIO, NBIX, PSTV, RIGL, RTRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | RTRX | Travere Therapeuti ... | LYONS GARY A | Director | Option Exercise | A | 18.27 | 9,000 | 164,430 | 9,000 | |
| May 18 2021 | RTRX | Travere Therapeuti ... | LYONS GARY A | Director | Grant | A | 0.00 | 3,000 | 0 | 37,000 | 34 K to 37 K (+8.82 %) |
| May 19 2020 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Option Exercise | A | 15.43 | 9,000 | 138,870 | 9,000 | |
| May 19 2020 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Grant | A | 0.00 | 3,000 | 0 | 34,000 | 31 K to 34 K (+9.68 %) |
| May 10 2019 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Grant | A | 0.00 | 2,000 | 0 | 31,000 | 29 K to 31 K (+6.90 %) |
| May 11 2018 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Option Exercise | A | 26.52 | 10,000 | 265,200 | 10,000 | |
| May 11 2018 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Grant | A | 0.00 | 2,500 | 0 | 29,000 | 26.5 K to 29 K (+9.43 %) |
| May 18 2017 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Option Exercise | A | 17.44 | 10,000 | 174,400 | 10,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Grant | A | 0.00 | 2,500 | 0 | 26,500 | 24 K to 26.5 K (+10.42 %) |
| May 19 2016 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Option Exercise | A | 16.33 | 8,000 | 130,640 | 8,000 | |
| May 19 2016 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Grant | A | 0.00 | 2,000 | 0 | 24,000 | 22 K to 24 K (+9.09 %) |
| Jun 10 2015 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Option Exercise | A | 32.59 | 8,000 | 260,720 | 8,000 | |
| Jun 10 2015 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Grant | A | 0.00 | 2,000 | 0 | 22,000 | 20 K to 22 K (+10.00 %) |
Page: 1